🇺🇸 FDA

Drug profile · INN

cyclosporine

RESTASIS

approved
US status
approved
Patents linked
8
News articles
0

Quick answer

cyclosporine (RESTASIS) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.

Key facts

INN cyclosporine
Brand RESTASIS
Route OPHTHALMIC
Formulation EMULSION
Originator Amneal Pharma Europe Ltd

Related patents

Search patents →

  1. US 12409206

    Use of cyclosporine analogues for treating fibrosis

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10472394

    Cyclosporine analogue mixtures and their use as immunomodulating agents

    Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9765119

    Cyclosporine analogue mixtures and their use as immunomodulating agents

    Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7521421

    Deuterated cyclosporine analogs and methods of making the same

    Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7332472

    Cyclosporine analogue mixtures and their use as immunomodulating agents

    Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 6998385

    Cyclosporine analogue mixtures and their use as immunomodulating agents

    Expires Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6686454

    Antibodies to specific regions of cyclosporine related compounds

    Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6613739

    Deuterated cyclosporine analogs and their use as immunomodulating agents

    Expires Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is cyclosporine?

cyclosporine (RESTASIS) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.

What is the brand name for cyclosporine?

RESTASIS is a marketed brand name for cyclosporine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of cyclosporine?

cyclosporine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.